Ali Waiswa
ID: UNCST-2025-R020882
|
ARTIFICIAL INTELLIGENCE AND DEEP LEARNING BASED IRIDOLOGY FOR DETECTION OF COLORECTAL CANCER
REFNo: HS6756ES
To determine the sensitivity of AI and deep learning based iridology for detection of colorectal cancer in Uganda over a period of one year.
To determine the specificity of AI and deep learning based iridology for detection of colorectal cancer in Uganda over a period of one year.
|
Uganda |
2025-11-13 16:40:17 |
2028-11-13 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
HAKIIMU KAWALYA
ID: UNCST-2025-R020311
|
Sickle Cell Modifier Genes Across Diverse Human Populations
REFNo: HS6710ES
1) To profile the most common fetal hemoglobin associated sickle cell disease modifier genes
2) To determine population specific gene expression patterns of fetal hemoglobin associated sickle cell disease modifier genes
3) To characterize inter-population Allele Frequencies of fetal hemoglobin associated sickle cell disease modifier gene variants
4) To analyze selection signals in fetal hemoglobin associated sickle cell modifier genes using human whole genome sequencing data
|
Uganda |
2025-11-13 15:27:46 |
2028-11-13 |
Medical and Health Sciences |
Non-Clinical Trial |
Degree Award |
|
Isaac Ssewanyana
ID: UNCST-2020-R014336
|
Partial Analytical and Clinical Performance Study focusing on Specimen Type Equivalence, Diagnostic Sensitivity and Specificity, and Usability Evaluation of ConfiSign HCV Pro.
REFNo: HS6742ES
3. Qualification of usability for professional use of ConfiSign HCV Pro through a label comprehension study and a results interpretation study which are to be completed by at least 3 laboratory professionals and at least 4 lay providers/healthcare workers.,2. Establish part of the clinical performance (diagnostic sensitivity and specificity) of ConfiSign HCV Pro using capillary whole blood samples.,1. Demonstrate the specimen type equivalence between capillary whole blood, venous whole blood, serum and plasma samples while using ConfiSign HCV Pro.,The general objective of this study is the partial evaluation of both clinical and analytical performance as well as qualification of usability for professional use of the ConfiSign HCV Pro according to parts of WHO TSS-16 (Part 1 - section 1.2.1, Part 2a - sections 2a.1.1 to 2a.1.3, Part 3a - sections 3a.1.1 to 3a.1.2) and CS (Annex I - Part I and Part II and Annex V - Table 2). For further details, see section 7.4.,
|
Uganda |
2025-11-07 5:14:01 |
2028-11-07 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Caroline Gotsche Isabelle
ID: UNCST-2025-R021504
|
Antenatal syphilis testing in central Uganda - Exploring provider-level factors affecting maternal syphilis testing coverage
REFNo: HS6671ES
1. Mapping the current body of literature of syphilis testing in ANC services.This will allow us to obtain an overview on the current state of syphilis testing among pregnant women in ANC services in Uganda.
2. Understanding impeding and facilitating factors of syphilis testing in ANC services.
Investigating providers` (Health Care Workers (HCW), midwives, nurses and physicians) knowledge of syphilis, and their experiences, perceptions, ideas and interest in syphilis testing will be essential to gain deeper understanding of these factors. Additionally, providers’ interest and ideas on engaging partners in antenatal syphilis testing will be explored to address the issue of re-infection in pregnant women. To gain an overview of a pregnant woman’s journey through the clinic, paying particular attention to how syphilis screening fits into antenatal care clinic observations will be conducted.
3. Exploring syphilis self-testing as a novel syphilis testing strategy in ANC services.
Investigating policy makers`, providers’ and pregnant women’s understanding and interest in the use of syphilis self-testing will be investigated. Whether the use of secondary distribution of self-test kits to partners of pregnant women to enhance partner engagement may be an acceptable approach among pregnant women will be also examined.
|
Germany |
2025-11-07 5:12:16 |
2028-11-07 |
Medical and Health Sciences |
Non-Clinical Trial |
Degree Award |
|
Nazarius Tumwesigye Mbona
ID: UNCST-2019-R000664
|
Promoting education and child well-being through the Education for Protection and Well-being model in Sironko and Budaka districts, Uganda: A cluster non-randomised controlled trial (EPW – Study)
REFNo: HS6277ES
4.1 General Objective
The purpose of this study is to assess the effectiveness of the EPW Program on children, caregivers, and teachers.
4.2 Specific Objectives
1. To assess the effectiveness of the EPW program by comparing intervention and control schools in terms of Student social-emotional learning (SEL) practices, Caregiver-child relationships and positive parenting practices and Teachers’ positive classroom management practices
2. To assess the prevalence of secondary outcomes for each participant group
3. To determine implementation factors (e.g., attendance, fidelity) that influence program effectiveness.
4. To establish the level of satisfaction, barriers and facilitators to participation in the program up to endline in intervention group.
|
Uganda |
2025-11-07 5:10:34 |
2028-11-07 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|